1. Home
  2. OLN vs NUVB Comparison

OLN vs NUVB Comparison

Compare OLN & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$20.36

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.01

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
NUVB
Founded
1892
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OLN
NUVB
Price
$20.36
$8.01
Analyst Decision
Hold
Strong Buy
Analyst Count
14
8
Target Price
$24.57
$9.63
AVG Volume (30 Days)
2.4M
10.2M
Earning Date
01-29-2026
11-03-2025
Dividend Yield
3.93%
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$6,787,000,000.00
$26,748,000.00
Revenue This Year
$3.82
$609.55
Revenue Next Year
$2.15
$197.91
P/E Ratio
$43.75
N/A
Revenue Growth
4.68
1137.19
52 Week Low
$17.66
$1.54
52 Week High
$43.33
$8.95

Technical Indicators

Market Signals
Indicator
OLN
NUVB
Relative Strength Index (RSI) 48.42 67.00
Support Level $20.00 $7.46
Resistance Level $21.80 $8.95
Average True Range (ATR) 0.90 0.67
MACD 0.15 0.05
Stochastic Oscillator 59.89 78.26

Price Performance

Historical Comparison
OLN
NUVB

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: